Abstract
Telomeres representing repetitive DNA sequences of chromosome ends are necessary for maintaining chromosomal integrity. The enzyme telomerase synthesizes de novo telomeric repeats and incorporates them onto the DNA 3′-ends of chromosomes. Stability of chromosome ends and activation of telomerase are elementary requirements for cell immortalization and tumor progression. The telomeric length and telomerase activity have been recently studied in several human neoplasms, including those of endocrine tissues. Assessment of telomerase activity may help to distinguish normal or hyperplastic from neoplastic tissues. Inhibition or inactivation of telomerase activity may provide novel strategies for cancer therapy.
Similar content being viewed by others
References
Muller, H. J. (1938). Woods Hole 13, 181–198.
McClintock, B. (1941). Genetics 41, 234–282.
Moyzis, R. K., Buckingham, J. M., Carm, K. S., Dani, M., Deaven, L. L., Jones, M. D., et al. (1988). Proc. Natl. Acad. Sci. USA 85, 6622–6626.
Olvonikov, A. M. (1973). J. Theor. Biol. 41, 181–190.
Harley, C. B. (1991). Mutat. Res. 9, 453–458.
Olvonikov, A. M. (1971). Doklady. Akademii Nauk. SSSR 201, 1496–1499.
Blackburn, E. H. (1991). Nature 350, 569–573.
Morin, G. B. (1989). Cell 59, 521–529.
Kim, N. W., Piatyzek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., et al. (1994). Science 266, 2011–2015.
Shay, J. W. and Wright, W. E. (1996). Trends Genet. 12, 129–131.
Hayflink, L. (1965). Exp. Cell Res. 37, 614–636.
Holt, S. E., Wright, W. E., and Shay, J. W. (1996). Mol. Cell Biol. 16, 2932–2939.
Anonymous (1996). Nature Genet. 14, 487.
Kontogeorgos, G. and Kovacs, K. (1997). Endocrine 5, 235–240.
Knight, S. J., Horsley, S. W., Regan, R., Lawrie, N. M., Maher, E. J., Cardy, D. L., et al. (1997). Eur. J. Hum. Genet. 5, 1–8.
Hou, J. W. and Wang, T. R. (1997). J. Formosian Med. Assoc. 96, 46–50.
Ohyashiki, K., Ohyashiki, J. H., Nishimaki, J., Toyama, K., Ebihara, Y., Kato, H., et al. (1997). Cancer Res. 57, 2100–2103.
Imam, S. A., Kim, M., Anker, L., Datar, R. H., Law, R. E., and Taylor, C. R. (1997). Anticancer Res. 17, 4435–4441.
Greider, C. W. and Blackburn, E. H. (1985). Cell 43, 405–413.
Aldous, W. K. and Grabill, N. R. (1997). Diagn. Mol. Pathol. 6, 102–110.
Shay, J. W. and Gazdar, A. F. (1997). J. Clin. Pathol. 50, 106–109.
DeMasters, B. K., Markham, N., Lillehei, K. O., and Shroyer, K. R. (1997). Am. J. Clin. Pathol. 107, 548–554.
Umbricht, C. B., Saji, M., Westra, W. H., Udelsman, R., Zeiger, M. A., and Sukumar, S. (1997). Cancer Res. 57, 2144–2147.
Haugen, B. R. Nawaz, S., Markham, N., Hashizumi, T., Shroyer, A. L., Werness, B., et al. (1997). Thyroid 7, 337–342.
Brousset, P., Chaouche, N., Lepart, F., Branet-Brousset, F., Trouette, H., Zenou, R. C., et al. (1997). J. Clin. Endocrinol. Metab. 82, 4214–4216.
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., and Shay, J. W. (1995). Nat. Med. 1, 249–255.
Hiyama, E., Kodama, T., Shinbara, K., Iwao, T., Itoh, M., Hiyama, K., Shay, J. W., et al. (1997). Cancer Res. 57, 326–331.
Harley, C. B. and Kim, N. W. (1996). Imp. Adv. Oncol. 57–67.
Sawyer, J. R., Swanson, C. M., Lukacs, J. L., Hassed, S. J., Curtis, M. A., North, P. E., et al. (1997). Am. J. Med. Genet. 69, 383–387.
Burger, A. M., Double, J. A., and Newell, D. R. (1997). Eur. J. Cancer 33, 638–644.
Wan, T. S., Chan, L. C., Ngan, H. Y., and Tsao, S. W. (1997). Cancer Genet. Cytogen. 95, 166–72.
Counter, C. M., Hirte, H. W., Bacchetti, S., and Harley, C. B. (1994). Proc. Natl. Acad. Sci. USA 91, 2900–2904.
Zheng, P. S., Iwasaka, T., Yamasaki, F., Ouchida, M., Yokoyama, M., Nakao, Y., et al. (1997). Gynecol. Oncol. 64, 171–175.
Murakami, J., Nagai, N., Ohama, K., Tahara, H., and Ide, T. (1997). Cancer 80, 1085–1092.
Wan, M., Li, W. Z., Duggan, B. D., Felix, J. C., Zhao, Y., and Dubeau, L. (1997). J. Natl. Cancer Inst. 89, 437–441.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., and Coffey, D. S. (1996). Cancer Res. 56, 218–222.
Kageyama, Y., Kamata, S., Yonese, J., and Oshima, H. (1997). Int. J. Urol. 4, 407–410.
Lin, Y., Uemura, H., Fujinami, K., Harada, M., and Kubota, Y. (1997). J. Urol. 157, 1161–1165.
Scates, D. K., Muir, G. H., Venitt, S., and Carmichael, P. L. (1997). Br. J. Urol. 80, 263–268.
Rogalla, P., Kazmierczak, B., Rohen, C., Trams, G., Bartnitzke, S., and Bullerdiek, J. (1994). Cancer Genet. Cytogen. 77, 19–25.
Rogalla, P., Rohen, C., Bonk, U., and Bullerdiek, J. (1996). Cancer Lett. 106, 155–161.
Odagiri, E., Kanada, N., Jibiki, K., Demura, R., Aikawa, E., and Demura, H. (1994). Cancer 73, 2978–2984.
Nawaz, S., Hashizumi, T. L., Markham, N. E., Shroyer, A. L., and Shroyer, K. R. (1997). Am. J. Clin. Pathol. 107, 542–547.
Sugino, T., Yoshida, K., Bolodeoku, J., Tahara, H., Buley, I., Manek, S., et al. (1996). Int. J. Cancer 69, 301–306.
Kyo, S., Takakura, M., Kohama, T., and Inoue, M. (1997). Cancer Res. 57, 610–614.
Saito, T., Schneider, A., Martel, N., Mizumoto, H., Bulgay-Moerschel, M., Kudo, R., et al. (1997). Biochem. Biophys. Res. Commun. 231, 610–614.
Brien, T. P., Kallakury, B. V., Lowry, C. V., Ambros, R. A., Muraca, P. J., Malfetano, J. H., et al. (1997). Cancer Res. 57, 2760–2764.
Morin, G. B. (1995). J. Natl. Cancer Inst. 87, 859–861.
Shay, J. W. (1995). Mol. Med. Today 1, 378–385.
Shay, J. W. and Woodring, E. W. (1996). Curr. Opinion Oncol. 8, 66–71.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kontogeorgos, G., Kovacs, K. Telomeres and telomerase in endocrine pathology. Endocr 9, 133–138 (1998). https://doi.org/10.1385/ENDO:9:2:133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:9:2:133